Detail (Long)
If intolerable side effects or inadequate improvement: May offer a different medication in the same class or a medication from a different class. [CP] For pts on antimuscarinics, switching to a β3 agonist may be more tolerable, due to apparently lower rates of common side effects, while maintaining efficacy.